Back to Authors

Pazdur, Richard M.

0000-0002-4771-9923

A5051520990 | I1320320070

Mayo Clinic

United States Food and Drug Administration

Citations 3

Designing Dose-Optimization Studies in Cancer Drug Development: Discussions with Regulators

Statistics in Biopharmaceutical Research | January 9, 2023 | Volume: 15 | Issue: 3 | Pages: 697-703

10.1080/19466315.2023.2166099

Evaluation of Treatment Effect in Underrepresented Population in Cancer Trials: Discussion with International Regulators

Statistics in Biopharmaceutical Research | September 23, 2022 | Volume: 15 | Issue: 2 | Pages: 450-456

10.1080/19466315.2022.2128404

Cancer Clinical Trials beyond Pandemic: Report of an American Statistical Association Biopharmaceutical Section Open Forum Discussion

Statistics in Biopharmaceutical Research | July 25, 2022 | Volume: 15 | Issue: 2 | Pages: 444-449

10.1080/19466315.2022.2103181